Comparison of comorbidities among severe and non ‐severe COVID‐19 patients in Asian versus non‐Asian populations: A systematic review and meta‐analysis
This study aimed to evaluate the comorbidities among severe and non-severe COVID-19 patients in Asian versus non-Asian populations.DesignSystemic review and Meta-analysis.MethodsA systematic literature search was conducted using PubMed, Embase, Scopus and the web of science Database up to 24 March 2021. Odds ratios were calculated using a random-effects model.ResultsWe identified 66 studies including 39 Asian and 27 non-Asian studies. This study demonstrated that the proportion of hypertension was significantly higher in severe group than in non-severe group for Asian (OR = 2.46) and non-Asian (OR = 1.60, 95% CI: 1.37–1.86,I2 = 84%;p < .00001) patients. Similarly, the proportion of diabetes, cardiovascular disease and chronic kidney disease was significantly higher in severe group than in non-severe group for both Asian and non-Asian studies. We found no statistically significant difference between the severe versus non-severe g roup for cancer (OR = 1.26) and chronic obstructive pulmonary disease (OR = 1.32) among non-Asian patients.
Source: Nursing Open - Category: Nursing Authors: Anju Puri,
Lin He,
Mohan Giri,
Chengfei Wu,
Qinghua Zhao Tags: RESEARCH ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chronic Kidney Disease | Chronic Obstructive Pulmonary | COVID-19 | Databases & Libraries | Diabetes | Endocrinology | Heart | Hypertension | Nurses | Nursing | Science | Statistics | Study | Urology & Nephrology